Editorial policy

Medical review: the standard, and where it stands today

The standard: a physician (MD or DO), pharmacist (PharmD) or registered dietitian reviews each page that discusses a drug, a dose, a side effect or a health claim, and again whenever it is materially updated, with the reviewer's name, credentials and the review date printed under the title. Where it stands today: every guide is checked against its sources by the PeptideSorted editorial team and shows "Reviewed by PeptideSorted Editorial Team". Clinical reviewers are being added; a page shows "Medical review" only once a named clinician has checked it. Who reviews, what they check and how reviewers are vetted is on the medical review page. Calculators are arithmetic and are checked by the author; they carry no medical review because they make no medical claim.

Sources are primary and linked inline

In order of preference: FDA prescribing information, FDA press releases and bulk-substance lists, peer-reviewed trials on PubMed, manufacturer pricing pages, and professional society guidance. Secondary sources (news, law-firm updates) are used only when no primary source exists, and are identified as such. Every page ends with a numbered source list.

Describe, never prescribe

Dose tables reproduce what a label or trial used, with the schedule and limits that document states. We do not write "take", "start at" or "you should". For peptides with no human trials, the dosage page says so and reports animal doses only to explain why they do not translate.

FDA status is the first fact on every profile

Approved, compoundable with a prescription, investigational, or not approved. The status tracker is the single source for the whole site and is updated the day a status changes; profiles are re-reviewed within one week of any change.

No sales of unapproved products

No vendor reviews, rankings, coupon codes or links to products labeled for research use. Affiliate relationships exist only with telehealth services that prescribe FDA-approved or legally compounded medications after a clinician consultation, and every such link has the disclosure printed beside it.

Re-review schedule

• GLP-1 pages (dose, side effects, cost, compounded): every 90 days, or within a week of a label or FDA action.
• Peptide profiles: every 180 days, or within a week of an FDA list change.
• Learn pages: every 12 months.

Corrections

Errors are fixed on the page, the review date is updated, and the change is listed with its date in the public corrections log. Report one through the contact page.

Sponsors and advertisers

Every sponsored placement is labeled "Sponsored". Sponsors never see or influence a guide, a news item or the newsletter's editorial sections, and no sponsor appears inside a dose table or a calculator result. We decline "research use only" peptide sellers, unlicensed pharmacies, steroids and SARMs, and any copy that promises a dose, a cure or a weight-loss result. The advertise page lists the full rules.

The newsletter

Sorted, the Tuesday email, follows the same rules as the site: primary sources, the same medical review, and no personal dosing advice. Every issue is published in the archive as a normal web page.

Use of AI tools

AI tools are used to research, draft and edit pages, check arithmetic and locate sources. Each figure on a page must trace to a source listed on that page. AI tools do not count as medical review: only a named, licensed clinician can mark a page as medically reviewed.